切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MST - Topoisomerases - Voltage-gated Calcium Channels (CaV)

29件产品中的 1-10

页面
每页
清除全部
  1. XMU-MP-1
    A8735 XMU-MP-1
     2 Citation
    Target: MST
    Summary: MST1/2的强效选择性抑制剂
      ≥41.6 mg/mL
      insoluble in H2O
  2. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  3. SNX 482
    B5351 SNX 482
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: 电压依赖性R型CaV2.3钙通道阻滞剂
      Soluble in H2O
  4. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  5. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  6. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  7. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  8. Amlodipine
    B1410 Amlodipine
    中文名: 氨氯地平
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: 钙通道阻滞剂
      ≥17.7 mg/mL
      insoluble in H2O
  9. Nitrendipine
    B1393 Nitrendipine
    中文名: 尼群地平
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: 钙通道阻滞剂
      ≥13.7 mg/mL
      insoluble in H2O
  10. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL

29件产品中的 1-10

页面
每页